Cancer Care Ontario | Cancer Care Ontario

Systemic Treatment Emergency Preparedness Guidance Document

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Role of Adjuvant Treatment in Resected Pancreatic Ductal Adenocarcinoma

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

The Role of Aromatase Inhibitors in the Treatment of Postmenopausal Women with Metastatic Breast Cancer

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer

An Endorsement of the 2025 Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the EOTTD, ESGO, GCIG, ISSTD